menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  • ReachMD Healthcare Image
    Medical News

    Drug Limits Dangerous Reactions to Allergy-Triggering Foods, Stanford Medicine-…

  • ReachMD Healthcare Image
    Medical News

    The Consumption of Certain Food Additive Emulsifiers Could Be Associated with t…

  • ReachMD Healthcare Image
    Medical News

    Full Term Birth, Low Birth Weight Linked to Poor Growth Outcomes

Programs

  • What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
    MinuteCE®

    What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?

    1.00 program credits
  • The Gene Messenger: Advancing Neurological Gene Therapy
    Medical Industry Feature

    The Gene Messenger: Advancing Neurological Gene Therapy

  • More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe…
    ACC Action Center

    More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia

  • Stopping aspirin after 1 month DAPT in ACS patients after stenting
    ACC Action Center

    Stopping aspirin after 1 month DAPT in ACS patients after stenting

  • Delivering Transformation: Reducing Maternal Mortality Through Systemic Change
    Medical Industry Feature

    Delivering Transformation: Reducing Maternal Mortality Through Systemic Change

  • Identifying the Signs and Symptoms of Low Testosterone
    Clinician's Roundtable

    Identifying the Signs and Symptoms of Low Testosterone

Clinical Practice

  • Deep Learner: Building AI to Improve Cardiovascular Care
    Medical Industry Feature

    Deep Learner: Building AI to Improve Cardiovascular Care

  • Severe Asthma: An Exploratory Study on Mucus Plugging
    Medical Industry Feature

    Severe Asthma: An Exploratory Study on Mucus Plugging

  • Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
    CME/CE

    Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP

    0.25 credits
  • Self-assessment on statin eligibility without prescription using a web app
    ACC Action Center

    Self-assessment on statin eligibility without prescription using a web app

  • Mechanism of Disease: Immunoglobulin A Nephropathy
    Medical Industry Feature

    Mechanism of Disease: Immunoglobulin A Nephropathy

  • No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
    ACC Action Center

    No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI

Doctors Lounge

  • Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
    CME/CE

    Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic

    0.25 credits
  • Recognizing and Addressing Medical Gaslighting in Healthcare
    NeuroFrontiers

    Recognizing and Addressing Medical Gaslighting in Healthcare

  • Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
    NeuroFrontiers

    Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment

  • Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Imp…
    Project Oncology®

    Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Improves Outcomes

  • How Artificial Intelligence Is Changing the Practice of Gastroenterology
    GI Insights

    How Artificial Intelligence Is Changing the Practice of Gastroenterology

  • Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Base…
    Project Oncology®

    Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Based on Mutation, Methylation, Aneuploidy, & Protein Biomarkers

CME

  • Preventing Ischemic Stroke in Today’s World
    MinuteCE®

    Preventing Ischemic Stroke in Today’s World

    1.50 program credits
  • Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction …
    CME/CE

    Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma

    0.25 credits
  • Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
    CME/CE

    Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

    0.25 credits
  • Understanding the Recent Advances in IgAN
    CME/CE

    Understanding the Recent Advances in IgAN

    0.25 credits
  • Extending Treatment Durability  With Next-Generation Neovascular AMD Therapies
    CME/CE

    Extending Treatment Durability With Next-Generation Neovascular AMD Therapies 

    0.50 credits
  • Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
    CME/CE Meeting

    April 29, 2024

    05:30 PM - 07:30 PM PST

    Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM

Industry Feature

  • Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
    Medical Industry Feature

    Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs

  • CMV Infection After Transplant: Who’s at Risk and How to Manage?
    Medical Industry Feature

    CMV Infection After Transplant: Who’s at Risk and How to Manage?

  • Advancing the Science of Anemia Due to CKD
    Medical Industry Feature

    Advancing the Science of Anemia Due to CKD

  • The Current Standard of Care and Unmet Need in Anemia of CKD
    Medical Industry Feature

    The Current Standard of Care and Unmet Need in Anemia of CKD

  • Prevalence and Burden of Anemia of CKD
    Medical Industry Feature

    Prevalence and Burden of Anemia of CKD

  • Diving into a Treatment for Seizure Clusters Through Patient Case Studies
    Medical Industry Feature

    Diving into a Treatment for Seizure Clusters Through Patient Case Studies

Schedule25 Apr 2024